These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 18307737)
21. Failing heart; remodel, replace or repair? Akar AR; Durdu S; Cubukçuoğlu Deniz G; Aslan A; Akçali KC; Ozyurda U Anadolu Kardiyol Derg; 2008 Nov; 8 Suppl 2():148-57. PubMed ID: 19028646 [TBL] [Abstract][Full Text] [Related]
22. Overexpression of prostaglandin EP3 receptors activates calcineurin and promotes hypertrophy in the murine heart. Meyer-Kirchrath J; Martin M; Schooss C; Jacoby C; Flögel U; Marzoll A; Fischer JW; Schrader J; Schrör K; Hohlfeld T Cardiovasc Res; 2009 Feb; 81(2):310-8. PubMed ID: 19019835 [TBL] [Abstract][Full Text] [Related]
23. The effect of estrogens on congestive failure and cardiac hypertrophy in hypertensive men. LEWIS JA; PATERSON JC; RAMSAY AG Can Serv Med J; 1957 Feb; 13(2):89-92. PubMed ID: 13396705 [No Abstract] [Full Text] [Related]
25. IGF-II/mannose-6-phosphate receptor signaling induced cell hypertrophy and atrial natriuretic peptide/BNP expression via Galphaq interaction and protein kinase C-alpha/CaMKII activation in H9c2 cardiomyoblast cells. Chu CH; Tzang BS; Chen LM; Kuo CH; Cheng YC; Chen LY; Tsai FJ; Tsai CH; Kuo WW; Huang CY J Endocrinol; 2008 May; 197(2):381-90. PubMed ID: 18434368 [TBL] [Abstract][Full Text] [Related]
26. Targeting histone deacetylases for heart failure. Bush EW; McKinsey TA Expert Opin Ther Targets; 2009 Jul; 13(7):767-84. PubMed ID: 19466913 [TBL] [Abstract][Full Text] [Related]
27. IGF1-PI3K-induced physiological cardiac hypertrophy: Implications for new heart failure therapies, biomarkers, and predicting cardiotoxicity. Bass-Stringer S; Tai CMK; McMullen JR J Sport Health Sci; 2021 Dec; 10(6):637-647. PubMed ID: 33246162 [TBL] [Abstract][Full Text] [Related]
28. Role of phosphoinositide 3-kinase in cardiac function and heart failure. Naga Prasad SV; Perrino C; Rockman HA Trends Cardiovasc Med; 2003 Jul; 13(5):206-12. PubMed ID: 12837584 [TBL] [Abstract][Full Text] [Related]
29. Molecular basis of physiological heart growth: fundamental concepts and new players. Maillet M; van Berlo JH; Molkentin JD Nat Rev Mol Cell Biol; 2013 Jan; 14(1):38-48. PubMed ID: 23258295 [TBL] [Abstract][Full Text] [Related]
30. Could a dose of stem cells heal a failing heart? Baldauf S US News World Rep; 2009 Dec; 146(11):59. PubMed ID: 20027822 [No Abstract] [Full Text] [Related]
32. "The failing heart"--recent advances in medical therapy. Chia BL Singapore Med J; 1992 Dec; 33(6):553-4. PubMed ID: 1488658 [No Abstract] [Full Text] [Related]
33. Modulating cardiac growth: a new paradigm in the treatment of heart failure. Introduction. Roberts R Clin Cardiol; 1995 Sep; 18(9 Suppl 4):IV2-3. PubMed ID: 7489616 [No Abstract] [Full Text] [Related]
34. THE FAILING heart; transcription of a panel meeting on therapeutics. Bull N Y Acad Med; 1954 Oct; 30(10):777-802. PubMed ID: 13199497 [No Abstract] [Full Text] [Related]
36. Massive hypertrophy of the heart with special reference to Bernheim's syndrome. EVANS LR; WHITE PD Am J Med Sci; 1948 Nov; 216(5):485-91. PubMed ID: 18893918 [No Abstract] [Full Text] [Related]
37. Biochemistry of hypertrophy and heart failure. Proceedings of the XVII World Congress of the International Society for Heart Research. July, 2001. Winnipeg, Canada. Mol Cell Biochem; 2003 Sep; 251(1-2):1-159. PubMed ID: 15085831 [No Abstract] [Full Text] [Related]
38. A clinico-pathological study of two cases of idiopathic cardiac hypertrophy with congestive failure. FOWLER M Med J Aust; 1947 May; 1(22):672-6. PubMed ID: 20250254 [No Abstract] [Full Text] [Related]
39. Cardiac hypertrophy and failure. Report of a symposium. Marburg, West Germany, June 26-28, 1986. J Cardiovasc Pharmacol; 1987; 10 Suppl 6():S1-177. PubMed ID: 2485013 [No Abstract] [Full Text] [Related]